Skip to content
November 18, 2024

Investment information for the new generation

Search

isracann biosciences

Isracann Biosciences (IPOT.C) received a foreign owner cannabis license from the Israeli Minister of Health today, according to a press release. Getting this license concludes Isracann’s regulatory compliance requirements…
Isracann Biosciences (IPOT.C) made the decision to go ahead and import their Canadian cannabis into Israel today, according to a press release. It’s an entirely logical choice as the…
Five days ago, the embattled Israeli government announced “a road map to legalize cannabis within one year” creating a regulated market for adult-use marijuana….
October 14, 2020 Isracann announced that “the government of Israel has officially enacted the legislation for the export of medical cannabis, clearing the way for sales abroad that the…
The beginning of recreational weed in Israel is likely to boost IPOT’s bottom line….
The Israeli Ministry of Economy signed a Free Export Order for medical cannabis last month. The order allows for the implementation of an earlier decision for medical cannabis that…
Isracann Biosciences (IPOT.C) is accelerating efforts to service an anticipated increase in demand for both domestic and EU markets. Isracanna is Israel’s only pure pot play—situated in one of…
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next…
There’s a lot going on underneath the surface with Isracann Biosciences (IPOT.C).  A year in review won’t be much, mostly because this company hasn’t been public for a year….